These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 38656258
1. Construction and validation of a predictive model for major adverse cardiovascular events in the long term after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Yang Y, Yin X, Zhang Y, Ren L. Coron Artery Dis; 2024 Sep 01; 35(6):471-480. PubMed ID: 38656258 [Abstract] [Full Text] [Related]
2. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction. Wang L, Wang Y, Wang W, Wang Z. Sci Rep; 2024 Jun 02; 14(1):12634. PubMed ID: 38824158 [Abstract] [Full Text] [Related]
3. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Fang C, Chen Z, Zhang J, Jin X, Yang M. Front Cardiovasc Med; 2022 Jun 02; 9():1050785. PubMed ID: 36620648 [Abstract] [Full Text] [Related]
4. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system. Huang L, Zhang J, Huang Q, Cui R, Chen J. BMC Cardiovasc Disord; 2023 Apr 17; 23(1):198. PubMed ID: 37069503 [Abstract] [Full Text] [Related]
5. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction. Qiu H, Zhu Y, Shen G, Wang Z, Li W. Clin Interv Aging; 2023 Apr 17; 18():453-465. PubMed ID: 36987461 [Abstract] [Full Text] [Related]
6. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention]. Ji C, Song F, Huang X, Qu X, Qiu N, Zhu J. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar 17; 35(3):299-304. PubMed ID: 36916344 [Abstract] [Full Text] [Related]
7. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI. Gao N, Qi X, Dang Y, Li Y, Wang G, Liu X, Zhu N, Fu J. BMC Cardiovasc Disord; 2020 Dec 09; 20(1):513. PubMed ID: 33297955 [Abstract] [Full Text] [Related]
8. Prognosis Analysis of Delayed Call Time for Chest Pain in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Direct Percutaneous Coronary Intervention. Yang Y, Zhang Y, Ren L. Clin Appl Thromb Hemost; 2023 Dec 09; 29():10760296231186811. PubMed ID: 37533332 [Abstract] [Full Text] [Related]
9. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study. Zhang KP, Guo QC, Mu N, Liu CH. Medicine (Baltimore); 2024 Jun 14; 103(24):e38563. PubMed ID: 38875361 [Abstract] [Full Text] [Related]
10. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Ying C, Liu CF, Guo DQ, Du ZR, Wei YJ. Clinics (Sao Paulo); 2023 Jun 14; 78():100306. PubMed ID: 37949037 [Abstract] [Full Text] [Related]
11. Establishment and validation of a nomogram model containing a triglyceride-glucose index and neutrophil-to-high-density lipoprotein ratio for predicting major adverse cardiac events in patients with ST-segment elevation myocardial infarction. Xu ZC, Pang LM, Chen M, Hu GQ. J Int Med Res; 2024 Sep 14; 52(9):3000605241258181. PubMed ID: 39291425 [Abstract] [Full Text] [Related]
13. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Machado GP, Araujo GN, Carpes CK, Lech M, Mariani S, Valle FH, Bergoli LCC, Gonçalves SC, Wainstein RV, Wainstein MV. Atherosclerosis; 2018 Jul 14; 274():212-217. PubMed ID: 29803159 [Abstract] [Full Text] [Related]
15. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention. Fu WX, Zhou TN, Wang XZ, Zhang L, Jing QM, Han YL. Chin Med J (Engl); 2018 Jun 20; 131(12):1420-1429. PubMed ID: 29893358 [Abstract] [Full Text] [Related]
16. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention. Liu HW, Han YL, Jin QM, Wang XZ, Ma YY, Wang G, Wang B, Xu K, Li Y, Chen SL. Chin Med J (Engl); 2018 Jun 20; 131(12):1412-1419. PubMed ID: 29893357 [Abstract] [Full Text] [Related]
17. Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center. Wolff G, Lin Y, Quade J, Bader S, Kosejian L, Brockmeyer M, Karathanos A, Parco C, Krieger T, Heinen Y, Perings S, Albert A, Icks A, Kelm M, Schulze V. Clin Res Cardiol; 2020 Feb 20; 109(2):235-245. PubMed ID: 31236693 [Abstract] [Full Text] [Related]